Oncolytics Biotech Inc
Company Profile
Business description
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatment. The other projects in the company's pipeline include, Bracelet-1 for treatment of Breast Cancer, Goblet cohort-1, Goblet cohort-5 for treatment of Gastro-Intestinal Cancer among others.
Contact
322 11th Avenue S.W
Suite 804
Calgary AB T2R 0C5
CANT: +1 403 670-7377
E: mmoore@oncolytics.ca
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2024
Employees
27
Stocks News & Analysis
video
Now the dust has settled, a mini earnings wrap
stocks
This moated ASX stock is swimming in cash
video
ASX shares to own forever
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 8,323.50 | 30.40 | 0.37% |
| CAC 40 | 7,465.25 | 30.18 | 0.41% |
| DAX 40 | 18,699.40 | 181.01 | 0.98% |
| Dow JONES (US) | 41,374.20 | 277.43 | 0.68% |
| FTSE 100 | 8,273.09 | 32.12 | 0.39% |
| HKSE | 17,369.09 | 128.70 | 0.75% |
| NASDAQ | 17,652.17 | 82.50 | 0.47% |
| Nikkei 225 | 36,581.76 | 251.51 | -0.68% |
| NZX 50 Index | 12,832.55 | 12.27 | 0.10% |
| S&P 500 | 5,620.74 | 24.98 | 0.45% |
| S&P/ASX 200 | 8,099.90 | 24.20 | 0.30% |
| SSE Composite Index | 2,704.09 | 13.03 | -0.48% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| Red 5 Ltd RED | 0.33 | 0.03 | 8.20% |
| Latin Resources Ltd LRS | 0.20 | 0.01 | 2.56% |
| Pilbara Minerals Ltd PLS | 2.90 | 0.02 | 0.69% |
| Bowen Coking Coal Ltd BCB | 0.01 | 0.00 | 0.00% |
| Telstra Group Ltd TLS | 3.96 | 0.00 | 0.00% |
| Appen Ltd APX | 1.55 | 0.05 | 3.33% |
| Imugene Ltd IMU | 0.05 | 0.00 | 0.00% |
| South32 Ltd S32 | 3.19 | 0.11 | 3.57% |
| Fortescue Ltd FMG | 17.50 | 0.84 | 5.04% |
| Resolute Mining Ltd RSG | 0.74 | 0.04 | 5.76% |